Skip to main content

Advertisement

SpringerLink
Log in

Is Vaginal Laser Effective for Overactive Bladder? Results of a Systematic Review

  • Overactive Bladder (U Lee and S Adelstein, Section Editors)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The aim of this review is to determine the efficacy of laser treatment in overactive bladder (OAB) syndrome in women.

Recent Findings

In international literature, there are few studies focusing on OAB symptoms. The proposed treatments included thulium laser, fractional CO2 laser and Erbium:YAG laser.

Summary

Although the analysed studies are not RCTs, the results show the efficacy of laser treatment in OAB symptoms, also compared to conventional medical and surgical treatments. However, these tests must be implemented with RCTs and with large patient samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20. https://doi.org/10.1002/nau.20798.

    Article  PubMed  Google Scholar 

  2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–15. https://doi.org/10.1016/j.eururo.2006.09.019.

    Article  PubMed  Google Scholar 

  3. Steward WF, Van Rooyen JB, CundiffGW AP, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36. https://doi.org/10.1007/s00345-002-0301-4.

    Article  Google Scholar 

  4. White N, Iglesia CB. Overactive Bladder. Obstet Gynecol Clin N Am. 2016;43:59–68. https://doi.org/10.1016/j.ogc.2015.10.002.

    Article  Google Scholar 

  5. Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6:S580–90.

    CAS  PubMed  Google Scholar 

  6. Nystrom E, Sjostrom M, Stenlund H, Samuelsson E. ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Neurourol Urodyn. 2014;34:747–51. https://doi.org/10.1002/nau.22657.

    Article  PubMed  Google Scholar 

  7. Thüroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, et al. EAU Guidelines on Urinary Incontinence. Eur Urol. 2011;59:387–400. https://doi.org/10.1016/j.eururo.2010.11.021.

    Article  PubMed  Google Scholar 

  8. • Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54:543–62. https://doi.org/10.1016/j.eururo.2008.06.047Review and meta-analysis on the main available medical therapy for OAB.

    Article  CAS  PubMed  Google Scholar 

  9. Liang CC, Hsieh WC, Huang L. Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery. Int Urogynecol J. 2016;28:605–11. https://doi.org/10.1007/s00192-016-3153-y.

    Article  PubMed  Google Scholar 

  10. Athanasiou S, Grigoriadis T, Giannoulis G, Protopapas A, Antsaklis A. Midurethral slings for women with urodynamicmixed incontinence: what to expect? Int Urogynecol J. 2013;24:393–9. https://doi.org/10.1007/s00192-012-1859-z.

    Article  PubMed  Google Scholar 

  11. Jain P, Jirschele K, Botros SM, Latthe PM. Effectiveness of midurethral slings in mixed urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2011;22:923–32. https://doi.org/10.1007/s00192-011-1406-3.

    Article  PubMed  Google Scholar 

  12. Lin YH, Hsieh WC, Huang L, Liang CC. Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol. 2017;56:815–20. https://doi.org/10.1016/j.tjog.2017.10.020.

    Article  PubMed  Google Scholar 

  13. •• Perino A, Cucinella G, Gugliotta G, Saitta S, Polito S, Adile B, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci. 2016;20:2491–7 One of the first trials on the application of laser CO 2for OAB symptoms.

    CAS  PubMed  Google Scholar 

  14. Ogrinc UB, Senčar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med. 2015;47:689–97. https://doi.org/10.1002/lsm.22416.

    Article  PubMed  PubMed Central  Google Scholar 

  15. •• Athanasiou S, Pitsouni E, Grigoriadis T, Zacharakis D, Falagas ME, Salvatore S, et al. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results. Menopause. 2019;26:248–55. https://doi.org/10.1097/GME.0000000000001206This is the most trial on efficacy of laser CO 2for the genitourinary syndrome of menopause.

    Article  PubMed  Google Scholar 

  16. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Int J Surg. 2010;8:336–41. https://doi.org/10.1016/j.ijsu.2010.02.007.

    Article  PubMed  Google Scholar 

  17. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

  18. Okui N. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol. 2019;37:885–9. https://doi.org/10.1007/s00345-018-2445-x.

    Article  PubMed  Google Scholar 

  19. •• Okui N. Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists. World J Urol. 2019. https://doi.org/10.1007/s00345-019-02644-7This trial compared erbium:YAG laser treatment vs standard medical therapy.

    Article  CAS  Google Scholar 

  20. Tovar-Huamani J, Mercado-Olivares F, Grandez-Urbina JA, Pichardo-Rodriguez R, Tovar-Huamani M, García-Perdomo H. Efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause in Latin American Population: First Peruvian experience. Lasers Surg Med. 2019;51:509–15. https://doi.org/10.1002/lsm.23066.

    Article  PubMed  Google Scholar 

  21. Athanasiou S, Pitsouni E, Antonopoulou S, Zacharakis D, Salvatore S, Falagas ME, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016;19:512–8. https://doi.org/10.1080/13697137.2016.1212006.

    Article  CAS  PubMed  Google Scholar 

  22. Pitsouni E, Grigoriadis T, Tsiveleka A, Zacharakis D, Salvatore S, Athanasiou S. Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas. 2016;94:131-136. https://doi.org/10.1016/j.maturitas.2016.09.012

    Article  Google Scholar 

  23. Pitsouni E, Grigoriadis T, Falagas ME, Salvatore S, Athanasiou S. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. Maturitas. 2017;103:78–88. https://doi.org/10.1016/j.maturitas.2017.06.029.

    Article  PubMed  Google Scholar 

  24. Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climateric. 2015;18:219–25. https://doi.org/10.3109/13697137.2014.975197.

    Article  CAS  Google Scholar 

  25. Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015;80:296–301. https://doi.org/10.1016/j.maturitas.2014.12.006.

    Article  PubMed  Google Scholar 

  26. •• Flint R, Cardozo L, Grigoriadis Rantell TA, Pitsouni E, Athanasiou S. Rationale and design for fractional microablative CO2 laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial. Climacteric. 2019;22:307–11. https://doi.org/10.1080/13697137.2018This trial compared CO2 laser and erbium:YAG laser for genitourinary syndrome of menopause.

    Article  CAS  PubMed  Google Scholar 

  27. Gaspar A, Maestri S, Silva J, Brandi H, Luque D, Koron N, Vižintin Z. Intraurethral Erbium: YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Lasers in surgery and medicine. 2018;50:802-807. https://doi.org/10.1002/lsm.22826

    Article  Google Scholar 

  28. Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. 2016;49:160–16. https://doi.org/10.1002/lsm.22569.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Drnovsek-Olup B, Beltram M, Pizem J. Repetitive Er:YAG laser irradiation of human skin: A histological evaluation. Lasers Surg Med. 2004;35:146–51. https://doi.org/10.1002/lsm.20080.

    Article  PubMed  Google Scholar 

  30. Tadir Y, Gaspar A, Lev-Sagie A, Alexiades M, Alinsod R, Bader A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies. Laser Surg Med. 2017;49:137–59. https://doi.org/10.1002/lsm.22637.

    Article  Google Scholar 

  31. Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17:363–9. https://doi.org/10.3109/13697137.2014.899347.

    Article  CAS  PubMed  Google Scholar 

  32. • Behnia-Willison F, Sarraf S, Miller J, Mohamadi B, Care AS, Lam A, et al. Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol. 2017;213:39–44. https://doi.org/10.1016/j.ejogrb.2017.03.036This trial reported data on long-term efficacy of CO 2laser for genitourinary syndrome of menopause.

    Article  PubMed  Google Scholar 

  33. Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg. 2011;28:156–62. https://doi.org/10.1177/074880681102800309.

    Article  Google Scholar 

  34. Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016:704–11. https://doi.org/10.1016/j.ajog.2016.07.045.

    Article  Google Scholar 

  35. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharm. 2006;148:565–78. https://doi.org/10.1038/sj.bjp.0706780.

    Article  CAS  Google Scholar 

  36. Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M, et al. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010;105:1276–82. https://doi.org/10.1111/j.1464-410X.2009.09036.x.

    Article  PubMed  Google Scholar 

  37. Kumar V, Templeman L, Chapple CR, Chess-Williams R. Recent developments in the management of detrusor overactivity. Curr Opin Urol. 2003;13:285–91. https://doi.org/10.1097/01.mou.0000079412.62186.66.

    Article  PubMed  Google Scholar 

  38. Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011;7:CD005493. https://doi.org/10.1002/14651858.CD005493.pub3.

    Article  Google Scholar 

  39. Adile B, Speciale P, Gugliotta G, Consiglio P, Manzone M, Adile G, et al. Efficacy and acceptance of the sacral neuromodulation in the treatment of female lower urinary tract dysfunctions. Minerva Ginecol. 2018;70:236–8. https://doi.org/10.23736/S0026-4784.17.04135-1.

    Article  PubMed  Google Scholar 

  40. McGuire EJ, Fitzpatrick CC, WanJ BD, Sanvordenker J, Ritchey M, et al. Clinical assessment of urethral sphincter function. J Urol. 1993;150:1452–4. https://doi.org/10.1016/s0022-5347(17)35806-8.

    Article  CAS  PubMed  Google Scholar 

  41. Smith P. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring. Acta Obstet Gynecol Scand. 1993;157:1–25.

    CAS  Google Scholar 

  42. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas. 1996;24:197–204.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obstetrics and Gynecology Unit, “Villa Sofia Cervello” Hospital, University of Palermo, via Trabucco 180, 90145, Palermo, Italy

    Gloria Calagna, Marianna Maranto, Emanuela Ognibene, Salvatore Polito & Gaspare Cucinella

  2. Department of Woman, Child and of General and Specialist Surgery, Second University of Naples, Naples, Italy

    Pasquale De Franciscis

  3. Obstetrics and Gynecology Unit, Department of Human Pathology of Adult and Childhood “G. Barresi”, University Hospital “G. Martino”, Messina, Italy

    Roberta Granese

Authors
  1. Gloria Calagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marianna Maranto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emanuela Ognibene
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Salvatore Polito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pasquale De Franciscis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberta Granese
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gaspare Cucinella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gloria Calagna.

Ethics declarations

Conflict of Interest

Gloria Calagna, Marianna Maranto, Ognibene Emanuela, Salvatore Polito, Pasquale De Franciscis, Roberta Granese and Gaspare Cucinella declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Overactive Bladder

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calagna, G., Maranto, M., Ognibene, E. et al. Is Vaginal Laser Effective for Overactive Bladder? Results of a Systematic Review. Curr Bladder Dysfunct Rep 14, 308–317 (2019). https://doi.org/10.1007/s11884-019-00535-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-019-00535-6

Keywords

Search

Navigation